---
document_datetime: 2024-12-03 11:32:04
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/lumykras-epar-all-authorised-presentations_en.pdf
document_name: lumykras-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.945899
conversion_datetime: 2025-12-27 13:49:33.648486
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging       | Pack size                         |
|------------------|-------------------|------------|-----------------------|---------------------------|---------------------------|-----------------------------------|
| EU/1/21/1603/001 | LUMYKRAS          | 120 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC/alu) | 240 x 1 tablets (unit dose)       |
| EU/1/21/1603/002 | LUMYKRAS          | 120 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC/alu) | 720 (3 x 240) tablets (multipack) |
| EU/1/21/1603/003 | LUMYKRAS          | 120 mg     | Film-coated tablet    | Oral use                  | bottle (HDPE)             | 240 (2 x 120) tablets             |
| EU/1/21/1603/004 | LUMYKRAS          | 240 mg     | Film-coated tablet    | Oral use                  | blister (PVC/ PCTFE/alu)  | 120 x 1 tablets (unit dose)       |